Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
28
XRAY Quote, Financials, Valuation and Earnings
Last price:
$11.22
Seasonality move
:
2.97%
Day range:
$11.05 - $11.23
52-week range:
$9.85 - $20.60
Dividend yield:
5.7%
P/E ratio:
--
P/S ratio:
0.62x
P/B ratio:
1.51x
Volume:
1.2M
Avg. volume:
3.6M
1-year change:
-40.63%
Market cap:
$2.2B
Revenue:
$3.8B
EPS (TTM):
-$4.43
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $3.3B | $4.2B | $3.9B | $4B | $3.8B | |
| Revenue Growth (YoY) | -17.06% | 26.6% | -7.3% | 1.1% | -4.34% | |
| Cost of Revenues | $1.6B | $1.9B | $1.8B | $1.9B | $1.8B | |
| Gross Profit | $1.7B | $2.3B | $2.1B | $2.1B | $2B | |
| Gross Profit Margin | 50.72% | 55.28% | 54.31% | 52.69% | 51.89% | |
| R&D Expenses | $115M | $171M | $174M | $184M | $165M | |
| Selling, General & Admin | $1.4B | $1.6B | $1.6B | $1.6B | $1.6B | |
| Other Inc / (Exp) | -$235M | -$19M | -$1.4B | -$383M | -$1.1B | |
| Operating Expenses | $1.4B | $1.7B | $1.8B | $1.8B | $1.7B | |
| Operating Income | $278M | $631M | $367M | $295M | $230M | |
| Net Interest Expenses | $62M | $66M | $50M | $64M | $55M | |
| EBT. Incl. Unusual Items | -$60M | $545M | -$1.1B | -$175M | -$936M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $23M | $134M | -$105M | -$43M | -$26M | |
| Net Income to Company | -$83M | $411M | -$950M | -$132M | -$910M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$83M | $411M | -$950M | -$132M | -$910M | |
| Basic EPS (Cont. Ops) | -$0.38 | $1.88 | -$4.41 | -$0.62 | -$4.48 | |
| Diluted EPS (Cont. Ops) | -$0.38 | $1.87 | -$4.41 | -$0.62 | -$4.48 | |
| Weighted Average Basic Share | $219.2M | $218.4M | $215.5M | $212M | $203.2M | |
| Weighted Average Diluted Share | $219.2M | $220.2M | $215.5M | $212M | $203.2M | |
| EBITDA | $612M | $977M | $695M | $638M | $579M | |
| EBIT | $278M | $631M | $367M | $295M | $230M | |
| Revenue (Reported) | $3.3B | $4.2B | $3.9B | $4B | $3.8B | |
| Operating Income (Reported) | $278M | $631M | $367M | $295M | $230M | |
| Operating Income (Adjusted) | $278M | $631M | $367M | $295M | $230M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $1B | $947M | $947M | $951M | $904M | |
| Revenue Growth (YoY) | 17.78% | -8.94% | -- | 0.42% | -4.94% | |
| Cost of Revenues | $469M | $440M | $451M | $456M | $463M | |
| Gross Profit | $571M | $507M | $496M | $495M | $441M | |
| Gross Profit Margin | 54.9% | 53.54% | 52.38% | 52.05% | 48.78% | |
| R&D Expenses | $39M | $41M | $46M | $40M | $37M | |
| Selling, General & Admin | $395M | $401M | $372M | $390M | $355M | |
| Other Inc / (Exp) | -$6M | -$1.3B | -$307M | -$524M | -- | |
| Operating Expenses | $431M | $442M | $417M | $428M | $392M | |
| Operating Income | $140M | $65M | $79M | $67M | $49M | |
| Net Interest Expenses | $15M | $15M | $18M | $16M | $23M | |
| EBT. Incl. Unusual Items | $113M | -$1.2B | -$250M | -$478M | -$230M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $29M | -$164M | $16M | $17M | $198M | |
| Net Income to Company | $84M | -$1.1B | -$266M | -$495M | -$428M | |
| Minority Interest in Earnings | -- | -- | -- | -$1M | -$1M | |
| Net Income to Common Excl Extra Items | $84M | -$1.1B | -$266M | -$495M | -$428M | |
| Basic EPS (Cont. Ops) | $0.38 | -$5.01 | -$1.26 | -$2.46 | -$2.14 | |
| Diluted EPS (Cont. Ops) | $0.38 | -$5.01 | -$1.26 | -$2.46 | -$2.14 | |
| Weighted Average Basic Share | $218.6M | $214.9M | $211.8M | $201M | $199.5M | |
| Weighted Average Diluted Share | $220.5M | $214.9M | $211.8M | $201M | $199.5M | |
| EBITDA | $225M | $147M | $167M | $156M | $142M | |
| EBIT | $140M | $65M | $79M | $67M | $49M | |
| Revenue (Reported) | $1B | $947M | $947M | $951M | $904M | |
| Operating Income (Reported) | $140M | $65M | $79M | $67M | $49M | |
| Operating Income (Adjusted) | $140M | $65M | $79M | $67M | $49M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $4.2B | $4B | $3.9B | $3.9B | $3.6B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $1.9B | $1.8B | $1.8B | $1.9B | $1.8B | |
| Gross Profit | $2.3B | $2.2B | $2.1B | $2B | $1.9B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $160M | $180M | $184M | $166M | $152M | |
| Selling, General & Admin | $1.6B | $1.6B | $1.6B | $1.6B | $1.5B | |
| Other Inc / (Exp) | -$22M | -$1.3B | -$431M | -$538M | -- | |
| Operating Expenses | $1.7B | $1.7B | $1.8B | $1.8B | $1.6B | |
| Operating Income | $630.4M | $475M | $306M | $264M | $271M | |
| Net Interest Expenses | $69.7M | $68M | $79M | $76M | $71M | |
| EBT. Incl. Unusual Items | $511.9M | -$907M | -$224M | -$356M | -$862M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $121.3M | -$91M | -$5M | $54M | $19M | |
| Net Income to Company | $387M | -$816M | -$219M | -$410M | -$881M | |
| Minority Interest in Earnings | $100K | -- | -$5M | $3M | $1M | |
| Net Income to Common Excl Extra Items | $390.6M | -$816M | -$219M | -$410M | -$881M | |
| Basic EPS (Cont. Ops) | $1.79 | -$3.81 | -$1.01 | -$2.07 | -$4.43 | |
| Diluted EPS (Cont. Ops) | $1.77 | -$3.81 | -$1.01 | -$2.07 | -$4.43 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $979M | $809M | $642M | $610M | $619M | |
| EBIT | $630.4M | $475M | $306M | $264M | $271M | |
| Revenue (Reported) | $4.2B | $4B | $3.9B | $3.9B | $3.6B | |
| Operating Income (Reported) | $630.4M | $475M | $306M | $264M | $271M | |
| Operating Income (Adjusted) | $630.4M | $475M | $306M | $264M | $271M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $3.1B | $2.9B | $3B | $2.9B | $2.7B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $1.4B | $1.3B | $1.4B | $1.4B | $1.3B | |
| Gross Profit | $1.7B | $1.6B | $1.6B | $1.5B | $1.4B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $122M | $131M | $141M | $123M | $110M | |
| Selling, General & Admin | $1.2B | $1.2B | $1.2B | $1.2B | $1.1B | |
| Other Inc / (Exp) | -$13M | -$1.3B | -$385M | -$540M | -$7M | |
| Operating Expenses | $1.3B | $1.3B | $1.3B | $1.3B | $1.2B | |
| Operating Income | $453M | $289M | $228M | $193M | $233M | |
| Net Interest Expenses | $45M | $43M | $61M | $57M | $61M | |
| EBT. Incl. Unusual Items | $389M | -$1.1B | -$232M | -$413M | -$339M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $97M | -$128M | -$28M | $69M | $114M | |
| Net Income to Company | $292M | -$935M | -$204M | -$482M | -$453M | |
| Minority Interest in Earnings | -- | -- | -$5M | -$2M | -$1M | |
| Net Income to Common Excl Extra Items | $292M | -$935M | -$204M | -$482M | -$453M | |
| Basic EPS (Cont. Ops) | $1.34 | -$4.35 | -$0.94 | -$2.39 | -$2.27 | |
| Diluted EPS (Cont. Ops) | $1.33 | -$4.36 | -$0.94 | -$2.39 | -$2.27 | |
| Weighted Average Basic Share | $655.8M | $646.8M | $638.2M | $614M | $597.9M | |
| Weighted Average Diluted Share | $661.1M | $648M | $639.4M | $615.1M | $598.6M | |
| EBITDA | $714M | $538M | $486M | $454M | $493M | |
| EBIT | $453M | $289M | $228M | $193M | $233M | |
| Revenue (Reported) | $3.1B | $2.9B | $3B | $2.9B | $2.7B | |
| Operating Income (Reported) | $453M | $289M | $228M | $193M | $233M | |
| Operating Income (Adjusted) | $453M | $289M | $228M | $193M | $233M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $438M | $339M | $365M | $334M | $272M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $673M | $750M | $632M | $695M | $556M | |
| Inventory | $466M | $515M | $627M | $624M | $564M | |
| Prepaid Expenses | $79M | $89M | $104M | $113M | $121M | |
| Other Current Assets | $67M | $84M | $88M | $113M | $153M | |
| Total Current Assets | $1.8B | $1.9B | $1.9B | $2B | $1.7B | |
| Property Plant And Equipment | $967M | $971M | $961M | $978M | $902M | |
| Long-Term Investments | -- | $11M | $25M | $4M | $23M | |
| Goodwill | $4B | $4B | $2.7B | $2.4B | $1.6B | |
| Other Intangibles | $2.5B | $2.3B | $1.9B | $1.7B | $1.2B | |
| Other Long-Term Assets | $95M | $121M | $198M | $276M | $301M | |
| Total Assets | $9.3B | $9.2B | $7.6B | $7.4B | $5.8B | |
| Accounts Payable | $305M | $262M | $279M | $305M | $241M | |
| Accrued Expenses | $432M | $424M | $401M | $427M | $480M | |
| Current Portion Of Long-Term Debt | $299M | $12M | $23M | $97M | $139M | |
| Current Portion Of Capital Lease Obligations | $48M | $50M | $54M | $56M | $46M | |
| Other Current Liabilities | $32M | $3M | $19M | $18M | $12M | |
| Total Current Liabilities | $1.3B | $1.3B | $1.2B | $1.4B | $1.6B | |
| Long-Term Debt | $2.1B | $2.1B | $2B | $1.9B | $1.7B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $4.4B | $4.2B | $3.8B | $4.1B | $3.8B | |
| Common Stock | $3M | $3M | $3M | $3M | $3M | |
| Other Common Equity Adj | -$464M | -$592M | -$628M | -$636M | -$730M | |
| Common Equity | $5B | $5B | $3.8B | $3.3B | $1.9B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $3M | $1M | $1M | $1M | $1M | |
| Total Equity | $5B | $5B | $3.8B | $3.3B | $1.9B | |
| Total Liabilities and Equity | $9.3B | $9.2B | $7.6B | $7.4B | $5.8B | |
| Cash and Short Terms | $438M | $339M | $365M | $334M | $272M | |
| Total Debt | $2.4B | $2.1B | $2.1B | $2.2B | $2.2B | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $281M | $418M | $309M | $296M | $363M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $732M | $645M | $649M | $671M | $654M | |
| Inventory | $548M | $592M | $651M | $619M | $686M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $243M | $284M | $304M | $335M | -- | |
| Total Current Assets | $1.8B | $1.9B | $1.9B | $1.9B | $2.1B | |
| Property Plant And Equipment | $954M | $915M | $935M | $967M | $972M | |
| Long-Term Investments | $11M | $69M | $18M | $5M | -- | |
| Goodwill | $4B | $2.6B | $2.4B | $1.9B | -- | |
| Other Intangibles | $2.4B | $1.9B | $1.7B | $1.5B | -- | |
| Other Long-Term Assets | $128M | $209M | $268M | $263M | -- | |
| Total Assets | $9.3B | $7.5B | $7.2B | $6.6B | $5.7B | |
| Accounts Payable | $271M | $271M | $262M | $297M | $268M | |
| Accrued Expenses | $641M | $711M | $732M | $798M | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $1.2B | $1.3B | $1.2B | $1.5B | $1.4B | |
| Long-Term Debt | $2.1B | $1.9B | $1.9B | $1.9B | $2.1B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $4.2B | $3.9B | $3.8B | $4.1B | $4.2B | |
| Common Stock | $3M | $3M | $3M | $3M | $3M | |
| Other Common Equity Adj | -$567M | -$844M | -$657M | -$638M | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $3M | $1M | -$4M | -$1M | -- | |
| Total Equity | $5.1B | $3.6B | $3.4B | $2.5B | $1.5B | |
| Total Liabilities and Equity | $9.3B | $7.5B | $7.2B | $6.6B | $5.7B | |
| Cash and Short Terms | $281M | $418M | $309M | $296M | $363M | |
| Total Debt | $2.2B | $2.1B | $2.1B | $2.3B | $2.5B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$83M | $411M | -$950M | -$132M | -$910M | |
| Depreciation & Amoritzation | $334M | $346M | $328M | $343M | $349M | |
| Stock-Based Compensation | $47M | $48M | $59M | $46M | $39M | |
| Change in Accounts Receivable | $126M | -$117M | $85M | -$58M | $104M | |
| Change in Inventories | $124M | -$64M | -$141M | $6M | $17M | |
| Cash From Operations | $635M | $657M | $517M | $377M | $461M | |
| Capital Expenditures | $87M | $142M | $149M | $149M | $180M | |
| Cash Acquisitions | $1.1B | $248M | -- | -- | -- | |
| Cash From Investing | -$1.1B | -$358M | -$138M | -$89M | -$197M | |
| Dividends Paid (Ex Special Dividend) | $88M | $92M | $104M | $116M | $126M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $1.5B | $16M | $6M | -- | $1M | |
| Long-Term Debt Repaid | -$701M | -$297M | -$2M | -$7M | -$88M | |
| Repurchase of Common Stock | $140M | $200M | $150M | $300M | $250M | |
| Other Financing Activities | -$56M | -$36M | -$15M | -$10M | -$16M | |
| Cash From Financing | $492M | -$379M | -$329M | -$307M | -$302M | |
| Beginning Cash (CF) | $438M | $339M | $365M | $334M | $272M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $33M | -$99M | $26M | -$31M | -$62M | |
| Ending Cash (CF) | $485M | $221M | $367M | $291M | $186M | |
| Levered Free Cash Flow | $548M | $515M | $368M | $228M | $281M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $84M | -$1.1B | -$266M | -$495M | -$428M | |
| Depreciation & Amoritzation | $85M | $82M | $88M | $89M | $92M | |
| Stock-Based Compensation | $22M | $14M | $2M | $12M | $6M | |
| Change in Accounts Receivable | -$74M | -$10M | $7M | -$67M | -$25M | |
| Change in Inventories | -$8M | -$45M | -$13M | $9M | -$14M | |
| Cash From Operations | $172M | $109M | $134M | $141M | $79M | |
| Capital Expenditures | $35M | $32M | $37M | $43M | $39M | |
| Cash Acquisitions | $7M | -- | -- | -- | -- | |
| Cash From Investing | -$40M | -$26M | -$2M | -$47M | -$36M | |
| Dividends Paid (Ex Special Dividend) | $24M | $27M | $29M | $33M | $32M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $143M | $28M | -$73M | $56M | -- | |
| Long-Term Debt Repaid | -$297M | -- | -$5M | -$2M | -- | |
| Repurchase of Common Stock | -- | -- | -- | $100M | -- | |
| Other Financing Activities | -$3M | -$7M | -$2M | -- | -- | |
| Cash From Financing | -$179M | -$6M | -$109M | -$79M | -$36M | |
| Beginning Cash (CF) | $281M | $418M | $309M | $296M | $363M | |
| Foreign Exchange Rate Adjustment | -$4M | -$21M | -$9M | $2M | -$3M | |
| Additions / Reductions | -$51M | $56M | $14M | $17M | $4M | |
| Ending Cash (CF) | $226M | $453M | $314M | $315M | $364M | |
| Levered Free Cash Flow | $137M | $77M | $97M | $98M | $40M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $387M | -$816M | -$219M | -$410M | -$881M | |
| Depreciation & Amoritzation | $348M | $334M | $337M | $346M | $347M | |
| Stock-Based Compensation | $65M | $41M | $45M | $48M | $29M | |
| Change in Accounts Receivable | -$113M | $15M | $11M | -$8M | $29M | |
| Change in Inventories | -$37M | -$116M | -$46M | $53M | -$46M | |
| Cash From Operations | $685M | $597M | $359M | $534M | $221M | |
| Capital Expenditures | $128M | $158M | $141M | $169M | $141M | |
| Cash Acquisitions | $1.3B | -- | -- | -- | -- | |
| Cash From Investing | -$1.4B | -$148M | -$98M | -$160M | -$144M | |
| Dividends Paid (Ex Special Dividend) | $90M | $102M | $112M | $125M | $127M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $163M | -$75M | $5M | $29M | -- | |
| Long-Term Debt Repaid | -$297M | -$2M | -$6M | -$9M | -- | |
| Repurchase of Common Stock | $90M | $260M | $150M | $400M | -- | |
| Other Financing Activities | -$11M | -$40M | -$7M | -$13M | -- | |
| Cash From Financing | -$258M | -$290M | -$340M | -$392M | -$19M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$991M | $137M | -$109M | -$13M | $67M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $557M | $439M | $218M | $365M | $80M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $292M | -$935M | -$204M | -$482M | -$453M | |
| Depreciation & Amoritzation | $261M | $249M | $258M | $261M | $259M | |
| Stock-Based Compensation | $54M | $47M | $33M | $35M | $25M | |
| Change in Accounts Receivable | -$89M | $43M | -$31M | $19M | -$56M | |
| Change in Inventories | -$88M | -$140M | -$45M | $2M | -$61M | |
| Cash From Operations | $435M | $375M | $217M | $374M | $134M | |
| Capital Expenditures | $101M | $117M | $109M | $129M | $90M | |
| Cash Acquisitions | $248M | -- | -- | -- | -- | |
| Cash From Investing | -$319M | -$109M | -$69M | -$140M | -$87M | |
| Dividends Paid (Ex Special Dividend) | $68M | $78M | $86M | $95M | $96M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $162M | $71M | $70M | $99M | $435M | |
| Long-Term Debt Repaid | -$297M | -$2M | -$6M | -$8M | -$274M | |
| Repurchase of Common Stock | $90M | $150M | $150M | $250M | -- | |
| Other Financing Activities | -$11M | -$15M | -$7M | -$10M | -$6M | |
| Cash From Financing | -$257M | -$168M | -$179M | -$264M | $19M | |
| Beginning Cash (CF) | $931M | $1.2B | $922M | $866M | $1.1B | |
| Foreign Exchange Rate Adjustment | -$16M | -$19M | -$25M | -$8M | $25M | |
| Additions / Reductions | -$157M | $79M | -$56M | -$38M | $91M | |
| Ending Cash (CF) | $758M | $1.2B | $841M | $820M | $1.2B | |
| Levered Free Cash Flow | $334M | $258M | $108M | $245M | $44M | |
Get XRAY Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
XRAY
Sector
P/E ratio
--
23.89x
PEG ratio
-0.02x
-0.01x
P/B ratio
1.51x
1.82x
Price / LTM sales
0.62x
1.60x
Growth Metrics
XRAY
Sector
Revenue growth
-4.94%
4.62%
Earnings growth
12.91%
10.88%
Revenue (5-year growth)
-1.2%
6.5%
Earnings forecast
$0.45
-$0.21
Profitability
XRAY
Sector
Profitability FY 2024
$2B
$3.5M
Return on invested capital
-20.14%
-31.77%
Return on assets
-14.61%
-27.96%
Return on equity
-44.58%
-37.63%
Earnings Date
Last Earnings Date
Nov
6
Next Earnings Date
Feb
26
Estimated Next Earnings Date
Feb
5
Balance Sheet
XRAY
Sector
Total cash
$363M
$26.3M
Short term investments
--
$25.7M
Total assets
$5.8B
$78M
Long term debt
$2.5B
$3.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
